Skip to main content

Table 1 Characteristics of people who inject drugs (n = 33) and report having been diagnosed with HCV (n = 26)*

From: Evidence-based and guideline-concurrent responses to narratives deferring HCV treatment among people who inject drugs

 

Overall n (%)

Sample with HCV n (%)

Socio-demographics

 City

  Boston

16 (48%)

15 (58%)

  Providence

17 (52%)

11 (42%)

 Age in years; median (interquartile range)

36 (32–48)

36 (30–44)

 Race (categories are not mutually exclusive)

  American Indian or Alaska Native

3 (9%)

2 (8%)

  Black or African American

7 (21%)

4 (15%)

  White

22 (67%)

21 (81%)

  Other

5 (15%)

3 (12%)

 Ethnicity: Hispanic/Latino

8 (24%)

6 (23%)

 Gender

  Male

18 (55%)

14 (54%)

  Female

13 (39%)

12 (46%)

  Transwoman

1 (3%)

0 (0%)

  Genderqueer

1 (3%)

0 (0%)

 Sexual orientation

  Heterosexual or “Straight”

21 (64%)

16 (62%)

  Bisexual

8 (24%)

7 (27%)

  Homosexual or Gay

4 (12%)

3 (12%)

Sexual health and substance use behaviors

  Diagnosed with HCV, ever

26 (79%)

26 (100%)

  Any distributive or receptive syringe sharing, past month

21 (64%)

18 (69%)

 Number of people with whom participant shared injection paraphernalia (cookers, cottons, rinse water), past month

  0

12 (36%)

8 (31%)

  1–2

10 (30%)

9 (35%)

  ≥ 3

11 (33%)

9 (35%)

  1. *May exceed 100% when categories were not mutually exclusive